What is Hemadri Cements Ltd (502133) share price return in the past 10 years?

Data is not available for this company

What is the share price of Hemadri Cements Ltd (502133)?

Company share prices are keep on changing according to the market conditions. The current trading price of Hemadri Cements Ltd (502133) on 21-Nov-2025 16:59:59 at 16:59 is 50.88.

What is the P/E ratio of Hemadri Cements?

The latest standalone P/E ratio of Hemadri Cements as of 21-Nov-2025 is 0.00.

What is the P/B ratio of Hemadri Cements Ltd (502133)?

The latest standalone P/B ratio of Hemadri Cements Ltd (502133) as of 21-Nov-2025 is -4.00.

What is the 52-week high and low of Hemadri Cements Ltd (502133)?

The 52-week high of Hemadri Cements Ltd (502133) is Rs. 70.20 and the 52-week low is Rs. 44.00.

Hemadri Cements Ltd (502133) Share Analysis – Order Book, Quality & Valuation Zone & DeciZen Rating

Name: Hemadri Cements Ltd (502133)
Brand: Hemadri Cements

Hemadri Cements Ltd (502133)

Key Metrics

Valuation Multiples

Market Cap

₹34 Cr.

Current Price

₹50.9

52-Week Low / High

₹44 / 70

TTM EPS

₹-27.8

TTM Sales

₹0 Cr.

Book Value per Share

₹-12.7

P/E Ratio

0.00

Industry PE

36.8

Price to Book (P/B)

-4.00

Lower than its 5-year historical median

Price to Sales (P/S)

0.00

Lower than its 5-year historical median

EV/EBITDA

-6.25

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-281.52%

Return on Capital Employed (ROCE)

-77.33%

Return on Assets (ROA)

-81.80%

Operating Profit Margin

-243.2%

Net Profit Margin

-340.53%

Gross Profit Margin

-246.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-85.77%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

66.31%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹-15 Cr.

Equity

₹6.7 Cr.

Face Value

₹10

All Time Low / High

₹0.50 / 157.60

Hemadri Cements stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	25.5%	17.1%	2%	2.7%	2.5%	7.8%	1.5%	-38.7%	-28.5%	-77.3%	-
Value Creation Index ⓘ	0.8	0.2	-0.9	-0.8	-0.8	-0.4	-0.9	-3.8	-3.0	NA	-
Growth Parameters ⓘ
Sales ⓘ	92.1	85.4	82.2	75.4	70.1	95.5	82.5	68.4	55.9	8	0
Sales YoY Gr.	-	-7.2%	-3.7%	-8.3%	-7.1%	36.2%	-13.7%	-17.1%	-18.3%	-85.8%	-
Adj EPS ⓘ	9.8	1.6	0.7	1.5	0.2	1.8	0.6	-22.9	-16.4	-40.6	-27.8
YoY Gr.	-	-83.3%	-55.2%	111%	-86.4%	757.1%	-64.4%	-3682.8%	NA	NA	-
BVPS (₹) ⓘ	67.7	69.4	70	71.5	71.6	73.6	74.3	51.3	34.5	-5.7	-12.7
Adj Net Profit ⓘ	6.5	1.1	0.5	1	0.1	1.2	0.4	-15.3	-10.9	-27.1	-19
Cash Flow from Ops. ⓘ	1.2	6	-0.9	-3.5	1.7	12.2	-5.4	-11.4	1.6	-6.9	-
Debt/CF from Ops. ⓘ	0	0	0	-1.9	3.5	0	-0.9	-1	7.1	-3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-23.8%	-35.3%	-54.2%	-85.8%
Adj EPS ⓘ	-217.1%	-386.6%	-498.8%	NA
BVPSⓘ	-176%	-160.3%	-142.5%	-116.5%
Share Price	-	-	-1.6%	-25%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	15.5	2.4	1.1	2.2	0.3	2.5	0.9	-36.5	-38.2	-281.7	301.6
Op. Profit Mgn % ⓘ	11.7	9.3	1.6	-2.6	2.8	5.8	1.5	-28.9	-18.9	-243.2	NAN
Net Profit Mgn % ⓘ	7.1	1.3	0.6	1.4	0.2	1.3	0.5	-22.4	-19.6	-340.7	-INF
Debt to Equity ⓘ	0	0	0	0.1	0.1	0	0.1	0.3	0.5	-5.4	0
Working Cap Days ⓘ	140	141	163	201	226	156	177	204	205	905	0
Cash Conv. Cycle ⓘ	24	25	43	65	79	53	62	91	115	652	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	92.05	85.42	82.23	75.42	70.10	95.49	82.46	68.37	55.86	7.95
Operating Expenses ⓘ +	81.27	77.47	80.88	77.38	68.13	89.92	81.26	88.11	66.40	27.27
Manufacturing Costs	27.86	51.02	52.01	47.82	38.33	51.67	50.86	52.67	41.30	9.42
Material Costs	40.54	13.85	12.79	12.20	11.10	10.57	9.76	12.23	4.23	2.11
Employee Cost	8.03	6.86	7.31	6.52	6.52	6.10	5.85	5.86	5.57	5.09
Other Costs ⓘ	4.84	5.74	8.77	10.84	12.18	21.59	14.79	17.35	15.30	10.65
Operating Profit ⓘ	10.78	7.95	1.35	-1.97	1.97	5.57	1.21	-19.73	-10.54	-19.33
Operating Profit Margin (%)	11.7%	9.3%	1.6%	-2.6%	2.8%	5.8%	1.5%	-28.9%	-18.9%	-243.0%
Other Income ⓘ +	0.94	0.89	0.76	4.46	0.43	0.38	1.75	2.32	1	1.11
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.16	0.02	0.02	0.70	0.91	0.09	0.36	1.11	1.40	1.41
Depreciation ⓘ	1.06	1.01	1.18	1.12	1.06	1.94	2.16	1.95	1.88	1.60
Profit Before Tax ⓘ	10.50	7.80	0.91	0.68	0.43	3.91	0.43	-20.46	-12.81	-21.22
Tax ⓘ	4	6.72	0.42	-0.35	0.29	2.71	0	-5.17	-1.88	5.84
Profit After Tax	6.50	1.09	0.49	1.03	0.14	1.20	0.43	-15.29	-10.93	-27.06
PAT Margin (%)	7.1%	1.3%	0.6%	1.4%	0.2%	1.3%	0.5%	-22.4%	-19.6%	-340.0%
Adjusted EPS (₹)	9.8	1.6	0.7	1.5	0.2	1.8	0.6	-22.9	-16.4	-40.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Hemadri Cements - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	45.27	46.30	46.85	47.81	47.87	49.08	49.55	34.22	23.03	-3.80
Share Capital ⓘ	6.67	6.67	6.67	6.67	6.67	6.67	6.67	6.67	6.67	6.67
Reserves ⓘ	38.60	39.63	40.18	41.14	41.20	42.41	42.88	27.55	16.36	-10.47
Debt +	0	0	0	6.72	5.90	0	4.78	11.54	11.36	20.12
Long Term Debt	0	0	0	0	0	0	0	1.61	1.60	20.12
Short Term Debt	0	0	0	6.72	5.90	0	4.78	9.93	9.76	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	4.14	3.53	2.27	4.38	3.66	5.19	6.73	4.18	5.80	3.58
Others Liabilities ⓘ	12.26	11.70	13.61	7.46	6.92	13.81	11.06	2.43	1.62	4.45
Total Liabilities ⓘ	61.67	61.53	62.73	66.37	64.36	68.08	72.12	52.38	41.81	24.35
Fixed Assets
Net Fixed Assets ⓘ +	7.88	11.07	10.55	10.14	18.50	16.67	14.88	13.55	12	10.49
Gross Block	42.88	12.08	12.74	48.45	57.87	57.98	58.08	58.70	58.96	58.87
Accumulated Depreciation	35	1.01	2.19	38.31	39.37	41.31	43.20	45.15	46.95	48.38
CWIP ⓘ	0.58	0	0.06	8.79	0	0	0.71	0.62	0.49	0.49
Investments ⓘ	0.60	0.60	0.60	0.60	0.60	0.60	0.60	0.60	0.60	0
Inventories	8.30	7.83	8.11	8.04	7.46	9.05	13.26	12.47	12.65	4.02
Trade Receivables	3.17	4.03	6.36	10.91	12.26	9.17	8.38	8.79	10.96	3.67
Cash Equivalents	12.88	14.07	11.77	3.63	1.77	12.74	14.14	2.85	0.75	1.94
Others Assets ⓘ	28.26	23.94	25.28	24.25	23.78	19.86	20.15	13.49	4.35	3.74
Total Assets ⓘ	61.67	61.53	62.73	66.37	64.36	68.08	72.12	52.38	41.81	24.35

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1.22	5.95	-0.86	-3.52	1.67	12.19	-5.38	-11.40	1.61	-6.92
PBT ⓘ	10.50	7.74	1.01	0.68	0.43	3.91	0.43	-20.46	-12.81	-21.22
Adjustment ⓘ	0.34	0.14	0.67	1.48	1.38	1.74	1.87	7.03	9.95	10.76
Changes in Working Capital ⓘ	-5.78	1.73	-1.49	-5.5	0.08	8.67	-7.55	1.04	4.45	3.52
Tax Paid ⓘ	-3.84	-3.66	-1.04	-0.17	-0.22	-2.13	-0.13	1	0.03	0.02
Cash Flow From Investing Activity ⓘ +	-1.12	-2.73	-0.20	-9.21	-0.26	0.19	-0.52	-0.16	0.03	0.16
Capex	-1.52	-3.62	-0.72	-9.44	-0.62	-0.11	-1.09	-0.53	-0.19	-0.05
Net Investments	0.32	0	0	0	0	0	0	0	0	0
Others ⓘ	0.08	0.89	0.52	0.23	0.37	0.30	0.57	0.37	0.22	0.22
Cash Flow From Financing Activity ⓘ +	-0.16	-0.02	-0.01	6.04	-1.61	-5.99	4.56	5.99	-1.57	7.91
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0.16	0	0	-0.68	-0.80	-0.08	-0.22	-0.77	-1.39	-1.38
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	-0.02	-0.01	6.72	-0.82	-5.90	4.78	6.76	-0.18	9.29
Net Cash Flow ⓘ	-0.06	3.20	-1.07	-6.68	-0.20	6.40	-1.33	-5.56	0.07	1.16

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	15.53	2.38	1.06	2.18	0.29	2.49	0.86	-36.51	-38.19	N/A
ROCE (%)	25.45	17.12	2.04	2.73	2.48	7.8	1.53	-38.67	-28.49	N/A
Asset Turnover Ratio	1.78	1.59	1.36	1.17	1.07	1.44	1.18	1.1	1.19	0.24
PAT to CFO Conversion(x)	0.19	5.46	-1.76	-3.42	11.93	10.16	-12.51	N/A	N/A	N/A
Working Capital Days
Receivable Days	14.80	13.40	20.60	41.80	60.30	41	38.80	45.80	64.50	336
Inventory Days	28.20	30.10	35.40	39.10	40.40	31.60	49.40	68.70	82.10	382.90
Payable Days	37.80	101.20	91.60	99.50	132.20	153	223.10	163	431	809.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hemadri Cements Ltd FAQs

The current trading price of Hemadri Cements on 21-Nov-2025 16:59 is ₹50.88.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Nov-2025 the market cap of Hemadri Cements stood at ₹33.94 Cr

The latest P/E ratio of Hemadri Cements as of 20-Nov-2025 is 0.00.

The latest P/B ratio of Hemadri Cements as of 20-Nov-2025 is -4.00.

The 52-week high of Hemadri Cements is ₹70.20 and the 52-week low is ₹44.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hemadri Cements is ₹0.00 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Hemadri Cements Ltd is a below average quality company.

The key valuation ratios of Hemadri Cements Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

No data found

About Hemadri Cements Ltd

Hemadri Cements Limited one of the leads in the Cement Manufacture industry, was incorporated as a Public Limited Company on April 20, 1981 under the provision of the Companies Act 1956. The registered office of the company is located at Hemadri Cements, Krishna District, Andhra Pradesh.

The plant was commissioned in March 1985. The manufactured cements for surpass all the stringent quality Control parameters set by the Bureau of Indian Standards (B.I.S) and the Research & Consultancy Directorate. Both Hemadri 43 Grade and Hemadri Gold 53 Grade O.P.C are manufactured using Vedadri Lime Stone, renowned to be one of the best lime stones available in the country. The result is cement which has a high compressive strength, consistency and chemical characteristics for superior to any other brand available in the market.

Business area of the company

The company is engaged in the production and sale of ‘cement’.

Hemadri Cements Ltd (502133)

Hemadri Cements Ltd (502133)

Hemadri Cements stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Hemadri Cements - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hemadri Cements Ltd FAQs

About Hemadri Cements Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Hemadri Cements Ltd (502133)

Hemadri Cements Ltd (502133)

Hemadri Cements stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Hemadri Cements - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hemadri Cements Ltd FAQs

What is the share price of Hemadri Cements?

What is the market cap of Hemadri Cements?

What is the P/E ratio of Hemadri Cements?

What is the P/B ratio of Hemadri Cements?

What is the 52-week high and low of Hemadri Cements?

What is the TTM revenue of Hemadri Cements?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Hemadri Cements Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.